LDLR and its role in Hepatitis B infection
Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics HBV – Hepatitis B virus infects more than 200 million people around the world. The virus results in liver diseases such as hepatitis, cirrhosis, fibrosis, and hepatocellular carcinoma (HCC). Prophylactic HBV vaccine reduces the number of infections but fails to offer a therapeutic benefit to chronically […]